Template-guided saturation prostate biopsies are no longer necessary when high-quality state-of- the-art multiparametric magnetic resonance image (mpMRI) is available, but suspicious lesions should always be confirmed by targeted biopsy, according to consensus panel findings published online ahead of print in BJU International.
The panel, which included urologic surgeons, radiologists, and basic researchers from Europe and North America, also concluded that mpMRI is the “optimum approach to achieve the objectives needed for focal therapy” if made on a high-quality machine and judged by an experienced radiologist. It also agreed that state-of-the-art mpMRI is the technique of choice for focal ablation follow-up, but concluded that mpMRI is not accurate enough to grade tumor aggressiveness consistently.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.